-
25-11-2020, 05:30 PM
#18601
I have just returned from a flexible cystoscopy - which showed nothing so since I have only ever had low grade tumours and the last one was three years ago - I have been discharged. That's all good, but when I asked why the cystoscopy was preferred /necessary this time rather than CX Bladder monitor, the urologist said that because of the outpatient clinic setup, it was cheaper than a urinary biomarker test.
He also said that he expected that (regardless of cost), CX Bladder was likely to be used in preliminary screening by GPs because there was a nationwide shortage of urologists.
-
25-11-2020, 06:28 PM
#18602
Member
Originally Posted by davflaws
I have just returned from a flexible cystoscopy - which showed nothing so since I have only ever had low grade tumours and the last one was three years ago - I have been discharged. That's all good, but when I asked why the cystoscopy was preferred /necessary this time rather than CX Bladder monitor, the urologist said that because of the outpatient clinic setup, it was cheaper than a urinary biomarker test.
He also said that he expected that (regardless of cost), CX Bladder was likely to be used in preliminary screening by GPs because there was a nationwide shortage of urologists.
It may also be there is a perverse situation where the DHB's are funded for cystoscopies and therefore it is better for their bottom line to get cystoscopies done rather than have the not inexpensive CxBladder tests done even though the former consumes more of the scarce urologist resource.
-
25-11-2020, 06:45 PM
#18603
Urologists.
Yep, someone's taking the piss...
Last edited by Getty; 25-11-2020 at 06:47 PM.
-
25-11-2020, 08:41 PM
#18604
Originally Posted by davflaws
I have just returned from a flexible cystoscopy - which showed nothing so since I have only ever had low grade tumours and the last one was three years ago - I have been discharged. That's all good, but when I asked why the cystoscopy was preferred /necessary this time rather than CX Bladder monitor, the urologist said that because of the outpatient clinic setup, it was cheaper than a urinary biomarker test.
He also said that he expected that (regardless of cost), CX Bladder was likely to be used in preliminary screening by GPs because there was a nationwide shortage of urologists.
Very pleased to hear that you have been discharged whichever way it was achieved.
-
26-11-2020, 07:20 AM
#18605
Member
Good morning all, when the result will be release on NZX website? sweet as.
-
26-11-2020, 07:22 AM
#18606
Originally Posted by Justin
Good morning all, when the result will be release on NZX website? sweet as.
Usually PEB has reported before market opens.
-
26-11-2020, 07:29 AM
#18607
From their investor news page:
“Pacific Edge would like to announce that half year results for the six months ending 30 September 2020 will be released on Thursday 26 November 2020, prior to 10am.”
-
26-11-2020, 07:38 AM
#18608
Originally Posted by thegreatestben
From their investor news page:
“Pacific Edge would like to announce that half year results for the six months ending 30 September 2020 will be released on Thursday 26 November 2020, prior to 10am.”
Probably for the first time in recent years, they could have added ' ... and we will not be announcing yet another rights issue!'
-
26-11-2020, 07:38 AM
#18609
Originally Posted by Balance
Usually PEB has reported before market opens.
Certainly hope they do, we dont want any repeats of that fiasco several years ago.
-
26-11-2020, 07:51 AM
#18610
Originally Posted by Minerbarejet
Certainly hope they do, we dont want any repeats of that fiasco several years ago.
Imo, sp is going to swing much higher or much lower on what gets reported with CMS & progress with collection of the US$40m backpay.
https://businessdesk.co.nz/article/l...-administrator
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks